Table V.
MLR | LWR | |||||
---|---|---|---|---|---|---|
Variables | <0.31 | ≥0.31 | P-value | <0.24 | ≥0.24 | P-value |
Age | ||||||
<60 years | 72 | 56 | 54 | 74 | ||
≥60 years | 88 | 52 | 0.271 | 55 | 85 | 0.629 |
Sex | ||||||
Male | 86 | 75 | 75 | 86 | ||
Female | 74 | 33 | 0.011 | 34 | 73 | 0.016 |
Stage | ||||||
III | 30 | 16 | 18 | 28 | ||
IV | 130 | 92 | 0.509 | 91 | 131 | 0.870 |
Histological type | ||||||
Adeno | 134 | 91 | 90 | 135 | ||
Sqcc | 26 | 17 | 1.000 | 19 | 24 | 0.615 |
Smoking history | ||||||
None | 83 | 50 | 49 | 84 | ||
Yes | 77 | 58 | 0.370 | 60 | 75 | 0.205 |
ECOG PS | ||||||
0 | 146 | 92 | 91 | 147 | ||
Others | 14 | 16 | 0.166 | 18 | 12 | 0.022 |
Tumor location | ||||||
Left | 60 | 52 | 49 | 63 | ||
Right | 100 | 56 | 0.083 | 60 | 96 | 0.385 |
Adeno, adenocarcinoma; ECOG PS, Eastern Cooperative Oncology Group performance score; LWR, lymphocyte/white blood cell ratio; MLR, monocyte/lymphocyte ratio; Sqcc, squamous cell carcinoma.